Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)
Clinical trial NCT04017455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04017455
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-22
- Primary completion
- 2025-08-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.